Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Hepatoprotection in Beta Thalassemia Major
NCT02984475Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in beta thalassemia major, sponsored by Cairo University. Primary endpoint: Alanine Aminotransferase and Aspartate Aminotransferase at 6 months. Status: unknown.
02
Drugs
metformin
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on NCT02984475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984475.